Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 7 December 2025

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

Published: December 7, 2025 Inovio Pharmaceuticals (NASDAQ: INO) has quietly turned 2025 into a make‑or‑break year. The small‑cap biotech has completed a Biologics License Application (BLA) for its lead DNA immunotherapy INO‑3107, raised fresh capital through two stock offerings, and attracted a flurry of new analyst ratings and algorithmic “Strong Buy” labels — all while still burning cash and generating minimal revenue. GuruFocus+3Yahoo Finance+3Stock Titan+3 As of the last trading session on Friday, December 5, 2025, INO stock closed at $2.07, up about 2.5% on the day and roughly 19–20% over the past 10 trading sessions, with around 1 million
7 December 2025
·····
Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Ticker: LUV – Coverage date: December 7, 2025 Southwest Airlines stock is back in the spotlight. As of the close on Friday, December 5, 2025, shares of Southwest Airlines Co. (NYSE: LUV) finished just under $38, near a new 52‑week high, after rallying roughly 20% over the past month and about 12–13% year to date.MarketBeat+1 The catch: this surge comes right after the airline cut its 2025 profit outlook because of a 43‑day U.S. government shutdown and higher fuel costs—and just as U.S. regulators waive an $11 million fine tied to Southwest’s infamous 2022 holiday meltdown.Reuters+1 Here’s a detailed look
7 December 2025
···
CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (NASDAQ: CLSK) has quietly turned into one of the loudest volatility machines in U.S. small caps: a Bitcoin miner, an emerging AI infrastructure play, and a stock that can move nearly 10% in a day without breaking a sweat. As of the close on December 5, 2025, CLSK traded around $13.7 per share, down roughly 8–9% on the day on very heavy volume of about 32–33 million shares. The selloff followed the release of “transformative” fiscal 2025 results that delivered triple‑digit revenue growth and a swing to substantial profit – but also missed Wall Street estimates and came with
7 December 2025
·····
KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

Updated: December 7, 2025 – Ticker: KULR (NYSE American) KULR Stock Snapshot: Price, Market Cap, and Volatility At the start of December 2025, KULR Technology Group’s share price is hovering around $3.93, with recent trading showing an intraday range between roughly $3.78 and $3.99 and volume around 1.36 million shares. That puts the company’s market capitalization near $180 million. Stock Titan Those calm-looking numbers sit on top of a pretty wild story: In other words, KULR is not a sleepy industrial. It’s a mash‑up of space‑grade battery tech and a leveraged Bitcoin balance sheet, and the stock trades accordingly. What
7 December 2025
·····
BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP stock is ending the first week of December in a strange but familiar place: cash is pouring out to shareholders, the share price is recovering, analysts are split, and the long‑term energy transition story is getting messier. As of the close on 5 December 2025, BP’s New York–listed ADRs (NYSE: BP) traded around $35.8 per share, while the London‑listed stock (LSE: BP.) changed hands at about 453p, putting the UK shares up roughly 18% over the past year.StockAnalysis+1 TradingView estimates BP’s dividend yield at about 5.4%, cementing its status as a high‑income name in the FTSE 100.TradingView Yet on
7 December 2025
····
Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Published: December 7, 2025 Nike’s stock has had a choppy 2025, and as of early December the story is less about sneakers and more about strategy: a leadership overhaul, pressure in China, a fresh dividend increase and a market still trying to decide whether NKE is a turnaround play or a value trap. Nike (NKE) Stock Price Snapshot Today Nike’s Class B shares (ticker: NKE) are trading around $65.86 per share, giving the company a market capitalization of roughly $97 billion. Google Key snapshot metrics as of this week: According to Zacks, the stock is down about 11% over the
7 December 2025
····
StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

As of December 7, 2025, sneakerheads, collectors and private‑market investors are all watching the same thing: “StockX stock”—even though the company still isn’t publicly listed on any exchange. StockX, the Detroit‑based marketplace that brands itself as the “stock market of things,” remains a private, venture‑backed company. But a growing ecosystem of pre‑IPO platforms, secondary brokers and data providers now publishes daily “StockX stock prices” and valuation estimates, and the company has just wrapped a busy 2025 filled with new products, legal milestones and impressive marketplace growth. AltInvests+1 This article pulls together the latest prices, news, forecasts and analyses around StockX
7 December 2025
····
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt offering, secured fresh regulatory wins in its cardiopulmonary and animal-health franchises, boosted its dividend, and simultaneously ran into a new patent roadblock for its subcutaneous Keytruda injection in Germany. PR Newswire+4Wikipedia+4Stock Titan+4 Against that backdrop, MRK stock is trading near the top of its 52‑week range, and Wall Street is sharpening its forecasts for 2026 and beyond. MRK stock price
7 December 2025
·····
Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Published: December 7, 2025 As the first full week of December wraps up, the Dow Jones Industrial Average is pressing up against the 48,000 line, sitting within striking distance of its all‑time highs. Investors are simultaneously cheering cooling inflation and a coming Federal Reserve rate cut, while parsing a thicket of 2026 forecasts that range from “bull market continues” to “recession risk rising.” This mix of optimism and unease is shaping the Dow Jones stock market narrative going into a pivotal week for Wall Street. Where the Dow Jones Stands Now The Dow Jones Industrial Average closed Friday, December 5,
7 December 2025
····
IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

As of December 7, 2025 The iShares Russell 2000 ETF (ticker: IWM) is back near its highs, trading around $250.77 after a powerful rebound in U.S. small‑cap stocks. The fund now sits close to its 52‑week peak near $252, up in the mid‑teens on a year‑to‑date basis, and well above its 52‑week low near $172. Investing.com+2Danelfin AI+2 At the same time, investors have poured billions into IWM, options activity has surged, and Wall Street strategists are suddenly bullish on small caps heading into 2026. So is IWM stock at the start of a new leadership cycle—or just another head fake
7 December 2025
····
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

As of 7 December 2025, Upstart Holdings (NASDAQ: UPST) sits right back in the market’s spotlight. The AI-powered consumer lender has delivered its strongest growth in years, secured multi‑billion‑dollar funding lines, and returned to GAAP profitability – yet its stock remains volatile, heavily shorted, and hotly debated on Wall Street. AlphaSense+1 This article rounds up the latest Upstart stock news, earnings, forecasts and analysis as of December 7, 2025, for readers tracking UPST on Google News and Discover. Upstart (UPST) stock price today: volatile AI lender with high short interest Upstart closed at about $46.75 per share in recent trading,
7 December 2025
·····
AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie’s stock is trading just below record highs as investors digest a powerful mix of rising earnings, a fresh dividend increase and a steady drumbeat of positive pipeline news in immunology, neuroscience and oncology. As of the close on Friday, December 5, 2025, AbbVie (NYSE: ABBV) finished at $226.08, down about 1.15% on the day and roughly 7–8% below its 52‑week high of $244.81 set on October 1.MarketWatch+1 That still leaves the company with a market capitalization around $400 billion, firmly placing it among the largest healthcare stocks globally.The Motley Fool+1 Below is a deep dive into the latest news,
7 December 2025
····
1 … 1,431 1,432 1,433 1,434 1,435 … 1,916

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop